Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Senior

Showing results (421-430 of 3,134) with videos related to

Pageof 314
Sort By:
Nature Biotechnology|May 17, 2020
Biotech companies prepare for COVID-19 downturnMelanie Senior
Neuron|May 27, 2003
Beauty in the brain of the beholderCarl Senior
Health Management Technology|October 21, 2006
Paper to EMR: A successful transitionTal Senior
The Lancet. Oncology|May 22, 2007
Age-specific PSA screening betterKathryn Senior
The Lancet. Oncology|August 30, 2007
Why is progress in treatment of cancer cachexia so slow?Kathryn Senior
Drug Discovery Today|March 8, 2005
Surprise neuroprotective potential of beta-lactam antibioticsKathryn Senior
The Lancet. Oncology|January 27, 2005
Growth-factor inhibition as therapy for Kaposi's sarcomaKathryn Senior
Drug Discovery Today|June 23, 2005
Novel second messenger offers drug development opportunitiesKathryn Senior
The Lancet. Oncology|June 6, 2017
Defining biochemical failure in prostate cancerKathryn Senior
The Lancet. Oncology|March 10, 2009
Battling cancer and the recessionKathryn Senior
Pageof 314

Showing results (421-430 of 3,134) with videos related to

Sort By:
Pageof 314
Nature Biotechnology|May 17, 2020
Biotech companies prepare for COVID-19 downturnMelanie Senior
Neuron|May 27, 2003
Beauty in the brain of the beholderCarl Senior
Health Management Technology|October 21, 2006
Paper to EMR: A successful transitionTal Senior
The Lancet. Oncology|May 22, 2007
Age-specific PSA screening betterKathryn Senior
The Lancet. Oncology|August 30, 2007
Why is progress in treatment of cancer cachexia so slow?Kathryn Senior
Drug Discovery Today|March 8, 2005
Surprise neuroprotective potential of beta-lactam antibioticsKathryn Senior
The Lancet. Oncology|January 27, 2005
Growth-factor inhibition as therapy for Kaposi's sarcomaKathryn Senior
Drug Discovery Today|June 23, 2005
Novel second messenger offers drug development opportunitiesKathryn Senior
The Lancet. Oncology|June 6, 2017
Defining biochemical failure in prostate cancerKathryn Senior
The Lancet. Oncology|March 10, 2009
Battling cancer and the recessionKathryn Senior
Pageof 314